Lifetime Costs of Surgical versus Medical Treatment of Severe Gastro-Oesophageal Reflux Disease in Finland

References

• Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastrooesophageal reflux disease in an adult population. Ann Med 1995; 27: 67–70
   PubMed Web of Science ®Google Scholar
• Nebel T O, Fornes M F, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Dig Dis Sci 1976; 21: 953–6
   Web of Science ®Google Scholar
• Wienbeck M, Barnert J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 1989; 24: 7–13, Suppl 156
   Web of Science ®Google Scholar
• Kitchin L I, Castell D O. Rationale and efficacy of conservative treatment for gastroesophageal reflux disease. Arch Intern Med 1991; 151: 448–54
   PubMedGoogle Scholar
• Havelund T, Laursen L S, Skoubo-Kristensen E, Andersen B N, Pedersen S A, Jensen K B, et al. Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial. Br Med J 1988; 296: 89–92
   PubMed Web of Science ®Google Scholar
• Sandmark S, Carlsson O, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol 1988; 23: 625–32
   PubMed Web of Science ®Google Scholar
• Laursen L S, Havelund T, Bondesen S, Hansen J, Sanchez G, Sebelin E, et al. Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study. Scand J Gastroenterol 1995; 30: 839–46
   PubMed Web of Science ®Google Scholar
• Dent J, Yeomans N D, Mackinnon M, Reed W, Narielvala F M, Hetzel D J, et al. Omeprazole v. ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. Gut 1994; 35: 590–8
   PubMed Web of Science ®Google Scholar
• Luostarinen M. Nissen fundoplication for reflux esophagitis. Long-term clinical and endoscopic results in 109 of 127 consecutive patients. Ann Surg 1993; 217: 329–37
   PubMed Web of Science ®Google Scholar
• Johansson J, Johnsson F, Joelsson B, Floren C-H, Walther B. Outcome 5 years after 360° fundoplication for gastro-oesophageal reflux disease. Br J Surg 1993; 80: 46–9
   PubMed Web of Science ®Google Scholar
• DeMeester T R, Bonavina L, Albertucci M. Nissen fundoplication for gastroesophageal reflux disease: evaluation of primary repair in 100 consecutive patients. Ann Surg 1986; 204: 9–20
   PubMed Web of Science ®Google Scholar
• Negre J B, Markkula H T, Keyrilainen O, Matikainen M. Nissen fundoplication. Results at 10 year follow-up. Am J Surg 1983; 146: 635–8
   PubMed Web of Science ®Google Scholar
• Shirazi S, Schulze K, Soper R. Long-term follow-up for treatment of complicated chronic reflux esophagitis. Arch Surg 1987; 122: 548–52
   PubMedGoogle Scholar
• Spechler S. Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med 1992; 326: 786–92
   PubMed Web of Science ®Google Scholar
• Isolauri J, Luostarinen M, Isolauri E, Reinikainen P, Viljakka M, Keyriläinen O. Natural course of gastroesophageal reflux disease; 17–22 year follow-up of 60 patients. Am J Gastroenterol 1997; 92: 37–41
   PubMed Web of Science ®Google Scholar
• Stein H J, DeMeester T R. Who benefits from antireflux surgery?. World J Surg 1992; 16: 313–9
   PubMed Web of Science ®Google Scholar
• Hetzel D J, Dent J, Reed W D, Narielvala F M, Mackinnon M, McCarthy J H, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903–12
   PubMed Web of Science ®Google Scholar
• van Den Boom G, Go PMMYH, Hameeteman W, Dallemagne B, Ament AJHA. Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in the Netherlands. Scand J Gastroenterol 1996; 31: 1–9
   PubMed Web of Science ®Google Scholar
• Coley C M, Barry M J, Spechler S J, Williford W O, Mulley AG. Initial medical v. surgical therapy for complicated or chronic gastroesophageal reflux disease (GERD). A cost-effectiveness analysis. Gastroenterology 1993; 104: A5
   Web of Science ®Google Scholar
• Bardhan K D, Daly M J, Singh S, Morris P, Thompson M, Hinchliffe RFC. Refractory esophagitis: results of maintenance treatment with high-dose H2-receptor antagonists (H2RA) or omeprazole (OM). Gastroenterology 1990; 98: A18
   Google Scholar
• Garnett W R. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease. Am J Hosp Pharm 1993; 50: Sll–8, Suppl
   Google Scholar
• Hillman A L. Economic analysis of alternative treatments for persistent gastro-oesophageal reflux disease. Scand J Gastroenterol 1994; 29: 98–102, Suppl 201
   Web of Science ®Google Scholar
• Lundell L, Backman L, Ekström P, Enander L-K, Falkmer S, Fausa O, et al. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol 1991; 26: 248–56
   PubMed Web of Science ®Google Scholar
• Klinkenberg-Knol E C, Jansen JBMJ, Lamers CBHW, Nelis F, Snel P, Meuwissen SGM. Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists. Scand J Gastroenterol 1989; 24: 88–93, Suppl 166
   Web of Science ®Google Scholar
• O'Hanrahan T, Marples M, Bancewicz J. Recurrent reflux and wrap disruption after Nissen fundoplication: detection, incidence and timing. Br J Surg 1990; 77: 545–7
   PubMed Web of Science ®Google Scholar
• Kuipers E J, Lundell L, Klinkenberg-Knol E C, Havu N, Festen HPM, Liedman B, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996; 334: 1018–22
   PubMed Web of Science ®Google Scholar
• Kauer WKH, Peters J H, DeMeester T R, Ireland A P, Bremner C G, Hagen J A. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juices alone. The need for surgical therapy re-emphazised. Ann Surg 1995; 222: 525–33
   PubMed Web of Science ®Google Scholar
• Stein H J, Barlow A P, DeMeester T R, Hinder R A. Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid\alkaline exposure, and duodenogastric reflux. Ann Surg 1992; 216: 35–43
   PubMed Web of Science ®Google Scholar
• Isolauri J, Luostarinen M, Viljakka M, Isolauri E, Keyrilainen O, Karvonen A-L. Long-term comparison of antireflux surgery vs conservative therapy for reflux esophagitis. Ann Surg 1997; 225: 295–9
   PubMed Web of Science ®Google Scholar